{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:51:32Z","timestamp":1781635892626,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Posterior Reversible Encephalopathy Syndrome (PRES) is a rare clinical and radiological condition. There is limited information regarding the characteristics of PRES in the Colombian population. This study aims to describe the clinical-radiological characteristics of PRES in a series of cases in Colombia. A retrospective study was conducted between 2018 and 2024 with adult patients with PRES in two high complexity centers in Bogota, Colombia. Demographic, clinical, radiological, electroencephalographic, neurological complications and clinical outcomes were registered. Comparison of outcomes was performed between patients with and without neurological complications (ischemia, hemorrhage, or status epilepticus). A bivariate logistic regression analysis was performed to determine the risk factors associated with neurological complications of PRES. We included 60 patients with a median age of 55 years, 68.3% women. The most frequent risk\/triggering factor was high systemic blood pressure (55%). Main symptoms reported were seizures (73.3%), impaired consciousness (60%), headache (43.3%) and visual changes (36.6%). Vasogenic cerebral edema was more common in the occipito-parietal region (33.3%). No fatalities were reported. The most frequent neurological complication was intracranial hemorrhage. Absence of complications was associated with shorter hospital stay (6 vs. 14 days). Additionally, a history of cerebrovascular disease and decreased visual acuity at presentation were associated with a lower observed rate of neurological complications following PRES (OR 0.1; 95% CI 0.01\u20130.91). Clinical-radiological characteristics of PRES in the Colombian population studied are similar to those described in literature. In our analysis, a history of cerebrovascular disease and decreased visual acuity at presentation were associated with a lower observed rate of neurological complications following PRES.<\/jats:p>","DOI":"10.1038\/s41598-026-38921-w","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:05:48Z","timestamp":1770469548000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Posterior reversible encephalopathy syndrome in Colombia a case series"],"prefix":"10.1038","volume":"16","author":[{"given":"M\u00f3nica","family":"Ortiz-Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Gaviria-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella Esther","family":"Mendoza-Rodelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ramirez-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Alejandra","family":"Palacios-Ariza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Roa-Wandurraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas Hernan","family":"Rodriguez Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"38921_CR1","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"334","author":"J Hinchey","year":"1996","unstructured":"Hinchey, J. et al. A reversible posterior leukoencephalopathy syndrome. N. Engl. J. Med. 334, 494\u2013500 (1996).","journal-title":"N. Engl. J. Med."},{"key":"38921_CR2","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00415-016-8377-8","volume":"264","author":"M Fischer","year":"2017","unstructured":"Fischer, M. & Schmutzhard, E. Posterior reversible encephalopathy syndrome. J. Neurol. 264, 1608\u20131616 (2017).","journal-title":"J. Neurol."},{"key":"38921_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/00207454.2016.1152966","volume":"127","author":"A Hinduja","year":"2017","unstructured":"Hinduja, A., Habetz, K., Raina, S., Ramakrishnaiah, R. & Fitzgerald, R. T. Predictors of poor outcome in patients with posterior reversible encephalopathy syndrome. Int. J. Neurosci. 127, 135\u2013144 (2017).","journal-title":"Int. J. Neurosci."},{"key":"38921_CR4","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.autrev.2015.05.006","volume":"14","author":"G Granata","year":"2015","unstructured":"Granata, G. et al. Posterior reversible encephalopathy syndrome\u2014insight into pathogenesis, clinical variants and treatment approaches. Autoimmun. Rev. 14, 830\u2013836 (2015).","journal-title":"Autoimmun. Rev."},{"key":"38921_CR5","doi-asserted-by":"publisher","first-page":"103080","DOI":"10.1016\/j.amsu.2021.103080","volume":"72","author":"S Iftikhar","year":"2021","unstructured":"Iftikhar, S. et al. The association of posterior reversible encephalopathy syndrome with COVID-19: a systematic review. Ann. Med. Surg. 72, 103080 (2021).","journal-title":"Ann. Med. Surg."},{"key":"38921_CR6","doi-asserted-by":"crossref","unstructured":"Lee, V. H., Wijdicks, E. F. M., Manno, E. M. & Rabinstein, A. A. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Arch. Neurol. 65, 859 (2008).","DOI":"10.1001\/archneurol.2007.46"},{"key":"38921_CR7","first-page":"16","volume":"12","author":"S Gungor","year":"2018","unstructured":"Gungor, S. et al. Clinical and imaging findings in childhood posterior reversible encephalopathy syndrome. Iran. J. Child. Neurol. 12, 16\u201325 (2018).","journal-title":"Iran. J. Child. Neurol."},{"key":"38921_CR8","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1212\/01.wnl.0000269780.45472.16","volume":"69","author":"OS Kozak","year":"2007","unstructured":"Kozak, O. S., Wijdicks, E. F. M., Manno, E. M., Miley, J. T. & Rabinstein, A. A. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 69, 894\u2013897 (2007).","journal-title":"Neurology"},{"key":"38921_CR9","doi-asserted-by":"crossref","unstructured":"Otite, F. O. et al. Demographic disparities in the Incidence, clinical Characteristics, and outcome of posterior reversible encephalopathy syndrome in the united States. Neurology 101, 5263 (2023).","DOI":"10.1212\/WNL.0000000000207604"},{"key":"38921_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00234-009-0504-0","volume":"51","author":"C Mueller-Mang","year":"2009","unstructured":"Mueller-Mang, C. et al. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance? Neuroradiology 51, 373\u2013383 (2009).","journal-title":"Neuroradiology"},{"key":"38921_CR11","doi-asserted-by":"crossref","unstructured":"Fugate, J. E. et al. Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clinic Proc. 85, 427\u2013432 (2010).","DOI":"10.4065\/mcp.2009.0590"},{"key":"38921_CR12","unstructured":"Lizarazo, J., Tibasosa, D. & Alandete, S. S\u00edndrome de encefalopat\u00eda posterior reversible. Acta Neurol. Colombiana 21, 526 (2005)."},{"key":"38921_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.seizure.2015.12.005","volume":"34","author":"K Heo","year":"2016","unstructured":"Heo, K. et al. Development of epilepsy after posterior reversible encephalopathy syndrome. Seizure 34, 90\u201394 (2016).","journal-title":"Seizure"},{"key":"38921_CR14","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/S1474-4422(25)00232-7","volume":"24","author":"JE Fugate","year":"2025","unstructured":"Fugate, J. E., Hawkes, M. A. & Rabinstein, A. A. Posterior reversible encephalopathy syndrome: evolving insights in diagnosis, management, and outcomes. Lancet Neurol. 24, 789\u2013800 (2025).","journal-title":"Lancet Neurol."},{"key":"38921_CR15","doi-asserted-by":"crossref","unstructured":"Triplett, J. D., Kutlubaev, M. A., Kermode, A. G. & Hardy, T. Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. Pract. Neurol. (2022).","DOI":"10.1136\/practneurol-2021-003194"},{"key":"38921_CR16","doi-asserted-by":"publisher","first-page":"421","DOI":"10.21037\/qims.2018.05.07","volume":"8","author":"Z Chen","year":"2018","unstructured":"Chen, Z. et al. Risk factors for poor outcome in posterior reversible encephalopathy syndrome: systematic review and meta-analysis. Quant. Imaging Med. Surg. 8, 421\u2013432 (2018).","journal-title":"Quant. Imaging Med. Surg."},{"key":"38921_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.reuma.2018.04.006","volume":"16","author":"JP Pirola","year":"2020","unstructured":"Pirola, J. P. et al. S\u00edndrome de leucoencefalopat\u00eda posterior reversible: serie de Casos y revisi\u00f3n de La literatura. Reumatol.Cl\u00edn. 16, 169\u2013173 (2020).","journal-title":"Reumatol.Cl\u00edn."},{"key":"38921_CR18","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00415-011-6152-4","volume":"259","author":"TG Liman","year":"2012","unstructured":"Liman, T. G., Bohner, G., Heuschmann, P. U., Endres, M. & Siebert, E. The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: the retrospective Berlin PRES study. J. Neurol. 259, 155\u2013164 (2012).","journal-title":"J. Neurol."},{"key":"38921_CR19","doi-asserted-by":"publisher","first-page":"135","DOI":"10.2169\/internalmedicine.7520-21","volume":"61","author":"Y Ando","year":"2022","unstructured":"Ando, Y., Ono, Y., Sano, A., Fujita, N. & Ono, S. Posterior reversible encephalopathy syndrome: a review of the literature. Intern. Med. 61, 135\u2013141 (2022).","journal-title":"Intern. Med."},{"key":"38921_CR20","doi-asserted-by":"publisher","first-page":"103239","DOI":"10.1016\/j.autrev.2022.103239","volume":"22","author":"Y Li","year":"2023","unstructured":"Li, Y., Song, J., Huq, A. M., Timilsina, S. & Gershwin, M. E. Posterior reversible encephalopathy syndrome and autoimmunity. Autoimmun. rev. 22, 103239 (2023).","journal-title":"Autoimmun. rev."},{"key":"38921_CR21","doi-asserted-by":"publisher","first-page":"4617","DOI":"10.1212\/WNL.96.15_supplement.4617","volume":"96","author":"A Tarabichi","year":"2021","unstructured":"Tarabichi, A., Ibrahim, F., Abbas, A. & Allam, H. COVID-19 associated posterior reversible encephalopathy syndrome (4617). Neurology 96, 4617 (2021).","journal-title":"Neurology"},{"key":"38921_CR22","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/S1474-4422(15)00111-8","volume":"14","author":"JE Fugate","year":"2015","unstructured":"Fugate, J. E. & Rabinstein, A. A. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 14, 914\u2013925 (2015).","journal-title":"Lancet Neurol."},{"key":"38921_CR23","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1136\/postgradmedj-2020-137706","volume":"96","author":"A Parasher","year":"2020","unstructured":"Parasher, A. & Jhamb, R. Posterior reversible encephalopathy syndrome (PRES): presentation, diagnosis and treatment. Postgrad. Med. J. 96, 623\u2013628 (2020).","journal-title":"Postgrad. Med. J."},{"key":"38921_CR24","doi-asserted-by":"publisher","first-page":"106250","DOI":"10.1016\/j.clineuro.2020.106250","volume":"198","author":"D Garrido","year":"2020","unstructured":"Garrido, D. et al. Triggers of posterior reversible encephalopathy in Guillain-Barre syndrome. Clin. Neurol. Neurosurg. 198, 106250 (2020).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"38921_CR25","doi-asserted-by":"publisher","first-page":"103017","DOI":"10.1016\/j.nicl.2022.103017","volume":"35","author":"S Fazeli","year":"2022","unstructured":"Fazeli, S., Noorbakhsh, A., Imbesi, S. G. & Bolar, D. S. Cerebral perfusion in posterior reversible encephalopathy syndrome measured with arterial spin labeling MRI. NeuroImage: Clin. 35, 103017 (2022).","journal-title":"NeuroImage: Clin."},{"key":"38921_CR26","doi-asserted-by":"crossref","unstructured":"Noro, F., De Mendon\u00e7a Cardoso, F. & Marchiori, E. COVID-19 and posterior reversible encephalopathy syndrome. Neur. Clin. Pract. 11, 5263 (2021).","DOI":"10.1212\/CPJ.0000000000000904"},{"key":"38921_CR27","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1212\/WNL.98.18_supplement.2051","volume":"98","author":"S Park","year":"2022","unstructured":"Park, S., Anwar, A., Saleem, S. & Ali, I. Meta-analysis of EEG findings in patients with PRES (P14-8.005). Neurology 98, 2051 (2022).","journal-title":"Neurology"},{"key":"38921_CR28","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s00404-015-3800-4","volume":"292","author":"M Cozzolino","year":"2015","unstructured":"Cozzolino, M. et al. Therapy and differential diagnosis of posterior reversible encephalopathy syndrome (PRES) during pregnancy and postpartum. Arch. Gynecol. Obstet. 292, 1217\u20131223 (2015).","journal-title":"Arch. Gynecol. Obstet."},{"key":"38921_CR29","doi-asserted-by":"publisher","first-page":"488","DOI":"10.5005\/jp-journals-10071-24492","volume":"27","author":"P Prasad","year":"2023","unstructured":"Prasad, P. Status epilepticus as a presenting feature in posterior reversible encephalopathy syndrome: tertiary care center experience. Indian J. Crit. Care Med. 27, 488\u2013492 (2023).","journal-title":"Indian J. Crit. Care Med."},{"key":"38921_CR30","doi-asserted-by":"crossref","unstructured":"Seitz, A. et al. Abstract WP155: epidemiology of posterior reversible encephalopathy syndrome (PRES) in the United States: a National inpatient sample study. Stroke 55, 2563 (2024).","DOI":"10.1161\/str.55.suppl_1.WP155"},{"key":"38921_CR31","doi-asserted-by":"publisher","first-page":"106579","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106579","volume":"31","author":"T Amornpojnimman","year":"2022","unstructured":"Amornpojnimman, T. et al. Predictors of hospital outcomes among patients with posterior reversible encephalopathy syndrome. J. Stroke Cerebrovasc. Dis. 31, 106579 (2022).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"38921_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00234-017-1815-1","volume":"59","author":"AD Schweitzer","year":"2017","unstructured":"Schweitzer, A. D. et al. Imaging characteristics associated with clinical outcomes in posterior reversible encephalopathy syndrome. Neuroradiology 59, 379\u2013386 (2017).","journal-title":"Neuroradiology"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38921-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38921-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38921-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:53:10Z","timestamp":1781632390000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-38921-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["38921"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-38921-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was revised and approved by the following ethical committees: Comit\u00e9 T\u00e9cnico de Investigaciones CIMED - Hospital Mayor M\u00e9deri and Comit\u00e9 de Investigaciones de la Fundaci\u00f3n Cardioinfantil \u2013 Instituto de Cardiolog\u00eda.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"7708"}}